IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caligan Partners LP

Q1 2026 Holdings

Filed 2026-05-15 | 28 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Liquidia Corporation(LQDA)COM NEW53635D202$306.4M8,118,89220.4%
Abivax SA(ABVX)SPONSORED ADS00370M103$162.8M1,461,92410.8%
Revolution Medicines Inc(RVMD)COM76155X100$160.7M1,652,80810.7%
Vaxcyte Inc(PCVX)COM92243G108$119.7M2,060,7198.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$81.0M1,393,0275.4%
Mineralys Therapeutics Inc(MLYS)COM603170101$75.1M2,772,6545.0%
Exelixis Inc(EXEL)COM30161Q104$66.6M1,553,2624.4%
CG Oncology Inc(CGON)CallCOM156944100$60.9M900,0004.1%
Tango Therapeutics Inc(TNGX)COM87583X109$50.4M2,408,7983.4%
Tyra Biosciences Inc(TYRA)COM90240B106$48.9M1,276,9683.3%
Spyre Therapeutics Inc(SYRE)COM NEW00773J202$44.3M878,1272.9%
Adma Biologics Inc(ADMA)COM000899104$42.9M4,756,5112.9%
LB Pharmaceuticals Inc(LBRX)COM SHS50180M108$34.6M1,438,0702.3%
VOR Biopharma Inc(VOR)COM NEW929033207$34.3M1,925,0662.3%
SAB Biotherapeutics Inc(SABS)COM NEW78397T202$30.5M7,967,2072.0%
Opus Genetics Inc(IRD)COM67577R102$27.6M6,075,0281.8%
Inventiva SA(IVA)ADS46124U107$27.6M4,974,9061.8%
MBX Biosciences Inc(MBX)COM55287L101$25.3M848,5901.7%
Avalo Therapeutics Inc(AVTX)COM NEW05338F306$24.4M1,635,0231.6%
Revolution Medicines Inc(RVMD)CallCOM76155X100$22.3M228,9001.5%
Anika Therapeutics Inc(ANIK)COM035255108$20.8M1,435,1301.4%
Maze Therapeutics Inc(MAZE)COM578784100$18.4M614,9621.2%
Verrica Pharmaceuticals Inc(VRCA)COM SHS92511W207$4.9M923,9100.3%
Sensei Biotherapeutics Inc(SNSE)COM NEW81728A207$4.0M126,0020.3%
Agios Pharmaceuticals Inc(AGIO)CallCOM00847X104$3.0M90,0000.2%
Adma Biologics Inc(ADMA)CallCOM000899104$2.7M300,0000.2%
Aura Biosciences Inc(AURA)COM05153U107$1.5M229,8640.1%
Xilio Therapeutics Inc(XLO)COM98422T209$943.0K112,1280.1%